Indian River State College Honors Veterans Day with Continued Commitment to Military Student Excellence
FORT PIERCE, Fla., Nov. 7, 2025 /PRNewswire/ — As the nation prepares to observe Veterans Day, Indian River State College reaffirms its dedication to serving... Read more.
Aquaporin A/S: Notice to convene an extraordinary general meeting
Company announcement No. 18/2025 Aquaporin A/S Nymøllevej 78DK-2800 Kongens Lyngbyaquaporin.comCompany registration no.: DK28315694 KONGENS LYNGBY, Denmark, Nov.... Read more.
Qount Unveils Next-Generation UX/UI Redesign — A Whole New Way for Firms to Work Smarter
PLANO, Texas, Nov. 7, 2025 /PRNewswire/ — Qount, the AI-driven Practice Intelligence Platform™ for public accounting firms, today announced the launch of... Read more.
Aquaporin A/S: Update on strategic review and intention to strengthen financial position
Company announcement No. 17/2025Inside information Aquaporin A/S Nymøllevej 78DK-2800 Kongens Lyngbyaquaporin.comCompany registration no.: DK28315694 KONGENS LYNGBY, Denmark,... Read more.
HiBy RS8 II Ultra-Flagship Portable HiFi Player Released
LEWES, Del., Nov. 7, 2025 /PRNewswire/ — HiBy has officially launched its new flagship portable HiFi player, RS8 II, on October 30, 2025. The RS8 II integrates... Read more.
Lunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 2025
Studies reveal how the Lunit SCOPE ® suite identifies immunotherapy-responsive subtypes, standardizes immune phenotyping, and accelerates antibody-based target... Read more.
Canaan Inc. Closes US$72 Million Registered Direct Offering with Brevan Howard, Galaxy Digital, and Weiss Asset Management
SINGAPORE, Nov. 7, 2025 /PRNewswire/ — Canaan Inc. (NASDAQ: CAN) (“Canaan” or the “Company”), an innovator in crypto mining, today announced... Read more.
HanchorBio Presents Two Late-Breaking Abstracts at the Society for Immunotherapy of Cancer 2025 Demonstrating Best-in-Class Potential of HCB101 in Advanced Cancers
Late-breaking poster presentations show HCB101’s favorable safety, strong receptor occupancy, and promising monotherapy and combination activity in tumors... Read more.
Cineverse to Report Second Quarter FY 2026 Financial Results on Friday, November 14, 2025
LOS ANGELES, Nov. 7, 2025 /PRNewswire/ — Cineverse Corp. (Nasdaq: CNVS), a next-generation entertainment studio, announced today that it will release its financial... Read more.
Diakonos Oncology Presents Promising Preliminary Data from Phase 1 Study of DOC1021 Cell-Based Immunotherapy in Pancreatic Cancer at Society for Immunotherapy of Cancer 40th Annual Meeting
HOUSTON, Nov. 7, 2025 /PRNewswire/ — Diakonos Oncology Corp., a clinical-stage biotechnology company developing a new generation of immunotherapies to treat... Read more.